The Trimeric Artesunate Analog TF27, a Broadly Acting Anti-Infective Model Drug, Exerts Pronounced Anti-SARS-CoV-2 Activity Spanning Variants and Host Cell Types

Starting in 2019, the spread of respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated pandemic of the corona virus disease (COVID-19) has led to enormous efforts in the development of medical countermeasures. Although innovative vaccines have scaled back the number of severe COVID cases...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Friedrich Hahn, Christina Wangen, Sigrun Häge, Lars Herrmann, Alexandra Herrmann, Svetlana B. Tsogoeva, Manfred Marschall
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	SARS-CoV-2 infection host-directed drug targeting artesunate and analogs trimeric analog TF27 broad-spectrum inhibitory properties pronounced anti-SARS-CoV-2 activity
Online Access:	https://www.mdpi.com/1999-4923/15/1/115